Browse by Aston Author

2016

Mirza, Kamran A., Luo, Menghua, Pereira, Suzette, Voss, Anne, Das, Tapas and Tisdale, Michael J. (2016). In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes. In Vitro Cellular and Developmental Biology: Animal, 52 (8), 838–845.

2014

Mirza, Kamran A., Pereira, Suzette L., Edens, Neile K. and Tisdale, Michael J. (2014). Attenuation of muscle wasting in murine C2C12myotubes by epigallocatechin-3-gallate. Journal of Cachexia, Sarcopenia and Muscle, 5 (4), pp. 339-345.

Mirza, K.A. and Tisdale, M.J. (2014). Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle. British Journal of Cancer, 111 (5), pp. 903-908.

2012

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG). Endocrinology, 153 (10), pp. 4696-4704.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). BBA - Molecular and Cell Biology of Lipids, 1821 (4), pp. 590-599.

2011

Tisdale, Michael (2011). Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, 2 (3), 181–188.

Mirza, Kamran, Wyke, Stacey M. and Tisdale, Michael (2011). Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF). British Journal of Cancer, 105 (1), pp. 83-88.

Russell, Steven and Tisdale, Michael (2011). Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat. International Journal of Obesity, 35 (5), pp. 658-665.

Russell, Steven and Tisdale, Michael (2011). Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse. International Journal of Obesity, 35 (3), pp. 345-354.

2010

Russell, Steven, Siren, Pontus M.A., Siren, Matus J. and Tisdale, Michael (2010). The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate. British Journal of Cancer, 102 (5), 833–836.

2009

Russell, Steve T., Siren, P.M.A., Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

2008

Russell, Steve T., Eley, Helen L., Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

Eley, H.L., Skipworth, R.J.E., Deans, D.A.C., Fearon, K.C.H. and Tisdale, Michael J. (2008). Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2 alpha may signal skeletal muscle atrophy in weight-losing cancer patients. British Journal of Cancer, 98 (2), pp. 443-449.

Yano, Claudia L., Ventrucci, Gislaine, Field, William N., Tisdale, Michael J. and Gomes-Marcondes, Maria Cristina C. (2008). Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer, 8 (24), 24-.

2007

Eley, H., Russell, S.T. and Tisdale, M.J. (2007). Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase. British Journal of Cancer, 96 (8), pp. 1216-1222.

2006

Bhogal, Ameek S., Lorite, Maria L. and Tisdale, Michael J. (2006). Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia. Anticancer Research, 26 (6B), pp. 4149-4154.

Bing, C., Russell, S., Becket, E., Pope, M., Tisdale, M.J., Trayhurn, P. and Jenkins, J.R. (2006). Adipose atrophy in cancer cachexia:morphologic and molecular analysis of adipose tissue in tumour-bearing mice. British Journal of Cancer, 95 (8), pp. 1028-1037.

Deans, D.A.C., Wigmore, S.J., Gilmour, H., Tisdale, Michael J., Fearon, Kenneth C.H. and Ross, J.A. (2006). Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy. British Journal of Cancer, 94 (5), pp. 731-736.

2005

Khal, J., Wyke, S.M., Russell, Steve T., Hine, Anna V. and Tisdale, Michael J. (2005). Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. British Journal of Cancer, 93 (7), pp. 774-780.

Sanders, P.M., Russell, S.T. and Tisdale, M.J. (2005). Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. British Journal of Cancer, 93 (4), pp. 425-434.

Smith, Helen J., Khal, Jwan and Tisdale, Michael J. (2005). Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid. Biochemical and Biophysical Research Communications, 332 (1), pp. 83-88.

Wyke, Stacey M. and Tisdale, Michael J. (2005). NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. British Journal of Cancer, 92 (4), pp. 711-721.

Russell, Steve T. and Tisdale, Michael J. (2005). The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. British Journal of Cancer, 92 (5), pp. 876-881.

Chand, Anita, Wyke, Stacey M. and Tisdale, Michael J. (2005). Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle. Cancer Letters, 218 (2), pp. 215-222.

2004

Wyke, S.M., Russell, Steve T. and Tisdale, Michael J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation. British Journal of Cancer, 91 (9), pp. 1742-1750.

Wynter, Michael P., Russell, Steve T. and Tisdale, Michael J. (2004). Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo, 18 (5), pp. 543-548.

Smith, Helen J., Greenberg, N.A. and Tisdale, Michael J. (2004). Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. British Journal of Cancer, 91 (2), pp. 408-412.

Smith, Helen J., Wyke, S.M. and Tisdale, Michael J. (2004). Role of protein kinase C and NF-kappa B in proteolysis-inducing factor-induced proteasome expression in C2C12 myotubes. British Journal of Cancer, 90 (9), pp. 1850-1857.

Sanders, P.M. and Tisdale, Michael J. (2004). Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage. British Journal of Cancer, 90 (6), pp. 1274-1278.

2003

Smith, Helen J. and Tisdale, Michael J. (2003). Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. British Journal of Cancer, 89 (9), pp. 1783-1788.

Whitehouse, A.S. and Tisdale, Michael J. (2003). Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappa B. British Journal of Cancer, 89 (6), pp. 1116-1122.

Whitehouse, A.S., Khal, J. and Tisdale, Michael J. (2003). Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway. British Journal of Cancer, 89 (4), pp. 737-745.

2002

Russell, S.T. and Tisdale, M.J. (2002). Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. British Journal of Cancer, 87 (5), pp. 580-584.

Gomes-Marcondes, Maria C.C., Smith, Helen J., Cooper, J.C. and Tisdale, Michael J. (2002). Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor. British Journal of Cancer, 86 (10), pp. 1628-1633.

Bing, C., Russell, S.T., Beckett, E.E., Collins, P., Taylor, S., Barraclough, R., Tisdale, M.J. and Williams, G. (2002). Expression of uncoupling proteins-1,-2 and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. British Journal of Cancer, 86 (4), pp. 612-618.

Russell, Steve T., Hirai, K. and Tisdale, Michael J. (2002). Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. British Journal of Cancer, 86 (3), pp. 424-428.

2001

Islam-Ali, B., Khan, S., Price, S.A. and Tisdale, Michael J. (2001). Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF). British Journal of Cancer, 85 (5), pp. 758-763.

Lorite, M.J., Smith, Helen J., Arnold, J.A., Morris, A., Thompson, M.G. and Tisdale, Michael J. (2001). Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). British Journal of Cancer, 85 (2), pp. 297-302.

Islam-Ali, B.S. and Tisdale, Michael J. (2001). Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation. British Journal of Cancer, 84 (12), pp. 1648-1655.

Belizario, J.E., Lorite, M.J. and Tisdale, Michael J. (2001). Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia. British Journal of Cancer, 84 (8), pp. 1135-1140.